Skip to main content
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1995 Jul;40(1):73–75. doi: 10.1111/j.1365-2125.1995.tb04537.x

Pharmacokinetics of ketoprofen enantiomers after different doses of the racemate.

G Geisslinger 1, S Menzel 1, K Wissel 1, K Brune 1
PMCID: PMC1365030  PMID: 8527271

Abstract

The pharmacokinetics of the enantiomers of ketoprofen after oral administration of 12.5 mg, 25 mg and 50 mg and i.v. administration of 50 mg racemic ketoprofen to 24 healthy subjects were investigated. The AUC values of R- (r2 = 0.929) and S-ketoprofen (r2 = 0.930) were proportional to dose. The absolute bioavailability of the 50 mg oral dose was 84.5 (s.d. 20.6) % and 81.4 (18.0) % for R-ketoprofen and S-ketoprofen, respectively. With the exception of AUC values no dose dependent differences in pharmacokinetic parameters were observed. However, the R-enantiomer had higher AUC, lower clearance data and higher Cmax values than the S-form after oral administration. The results suggest that stereochemical and pharmacokinetic considerations cannot explain the lack of dose response observed with ketoprofen doses below 50 mg.

Full text

PDF
73

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Foster R. T., Jamali F., Russell A. S., Alballa S. R. Pharmacokinetics of ketoprofen enantiomers in healthy subjects following single and multiple doses. J Pharm Sci. 1988 Jan;77(1):70–73. doi: 10.1002/jps.2600770113. [DOI] [PubMed] [Google Scholar]
  2. Foster R. T., Jamali F., Russell A. S., Alballa S. R. Pharmacokinetics of ketoprofen enantiomers in young and elderly arthritic patients following single and multiple doses. J Pharm Sci. 1988 Mar;77(3):191–195. doi: 10.1002/jps.2600770302. [DOI] [PubMed] [Google Scholar]
  3. Hayball P. J., Nation R. L., Bochner F., Sansom L. N., Ahern M. J., Smith M. D. The influence of renal function on the enantioselective pharmacokinetics and pharmacodynamics of ketoprofen in patients with rheumatoid arthritis. Br J Clin Pharmacol. 1993 Sep;36(3):185–193. doi: 10.1111/j.1365-2125.1993.tb04215.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Jamali F., Brocks D. R. Clinical pharmacokinetics of ketoprofen and its enantiomers. Clin Pharmacokinet. 1990 Sep;19(3):197–217. doi: 10.2165/00003088-199019030-00004. [DOI] [PubMed] [Google Scholar]
  5. Kantor T., Cavaliere M. B., Hopper M., Roepke S. A double-blind parallel comparison of ketoprofen, codeine, and placebo in patients with moderate to severe postpartum pain. J Clin Pharmacol. 1984 May-Jun;24(5-6):228–234. doi: 10.1002/j.1552-4604.1984.tb02778.x. [DOI] [PubMed] [Google Scholar]
  6. Mehlisch D., Frakes L., Cavaliere M. B., Gelman M. Double-blind parallel comparison of single oral doses of ketoprofen, codeine, and placebo in patients with moderate to severe dental pain. J Clin Pharmacol. 1984 Nov-Dec;24(11-12):486–492. doi: 10.1002/j.1552-4604.1984.tb02757.x. [DOI] [PubMed] [Google Scholar]
  7. Menzel-Soglowek S., Geisslinger G., Brune K. Stereoselective high-performance liquid chromatographic determination of ketoprofen, ibuprofen and fenoprofen in plasma using a chiral alpha 1-acid glycoprotein column. J Chromatogr. 1990 Nov 16;532(2):295–303. doi: 10.1016/s0378-4347(00)83780-9. [DOI] [PubMed] [Google Scholar]
  8. Sallustio B. C., Purdie Y. J., Whitehead A. G., Ahern M. J., Meffin P. J. The disposition of ketoprofen enantiomers in man. Br J Clin Pharmacol. 1988 Dec;26(6):765–770. doi: 10.1111/j.1365-2125.1988.tb05317.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Sunshine A., Zighelboim I., Laska E., Siegel C., Olson N. Z., De Castro A. A double-blind, parallel comparison of ketoprofen, aspirin, and placebo in patients with postpartum pain. J Clin Pharmacol. 1986 Nov-Dec;26(8):706–711. doi: 10.1002/j.1552-4604.1986.tb02977.x. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES